简体中文 | 繁體中文 | English

Press Releases

2022-02-07 15:16 causaLens Raises $45m Series A to Scale Human-centered AI That Understands Cause-and-effect
2022-02-07 15:13 LinKinVax and Inserm Transfert Enter Into an Exclusive Worldwide Licensing Agreement Covering Use of an Innovative Vaccine Platform
2022-02-07 14:51 Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium
2022-02-07 14:47 Kraken Launches Proof of Reserves Audits Allowing Clients to Verify Crypto Balances
2022-02-07 14:44 Additive Manufacturer Green Trade Association Announces New Members
2022-02-07 14:40 ROSEN, A LEADING LAW FIRM, Encourages Talkspace, Inc. Investors to Secure Counsel Before Important March 8 Deadline in Securities Class Action – TALK
2022-02-07 12:28 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages eHealth, Inc. Investors with Losses to Secure Counsel Before Important Updated March 18 Deadline in Securities Class Action – EHTH
2022-02-07 11:52 Energy Vault, Atlas Renewable and China Tianying Announce $100 Million Transaction With Further Upsized Pipe, Licensing and Royalty Agreement, and Initial 100MWh Project to Drive Decarbonization in China
2022-02-07 10:15 TTI Increasingly Excited about 2022
2022-02-07 10:00 Alpha Blue Ocean Announces a Financing of €3M With ADTHINK/NFTY
2022-02-07 09:52 BitMEX Welcomes New Head of Trading Bill Beller
2022-02-07 09:44 Merged Finsbury Glover Hering and Sard Verbinnen Rank #1 Globally in 2021 M&A Deal Count and Value
2022-02-07 09:41 ABB: Q4 2021 Results
2022-02-07 09:36 Nam Tai Property Announces Initiation of Legal Action Against Kaisa Group’s Wholly-Owned Affiliate Greater Sail
2022-02-07 09:34 Vifor Pharma appoints two new members to the Executive Committee
2022-02-07 09:31 XPeng Announces Vehicle Delivery Results for January 2022
2022-02-07 09:25 Block, Inc. Completes Acquisition of Afterpay
2022-02-07 09:22 KLDiscovery Introduces Nebula Singularity™ Global Subscription Service
2022-02-07 09:17 GWI Raises Over $180M to Continue Building the Future of Audience Insights Technology
2022-02-07 09:11 CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction